![Can cannabis treat mental illness? [FBKJkcs7mlw]](https://i.ytimg.com/vi/FBKJkcs7mlw/maxresdefault.jpg?focalcrop=2800x628x50x28&format=auto)
Hi all, the next science video is looking at cannabis/CBD to treat mental illness. This includes CBD for anxiety, depression, bipolar, ADHD, insomnia, schizophrenia, and PTSD. I go into the neuroscience behind cannabis and review recent research and future directions! Please like, subscribe, or comment below on your thoughts for future videos!
0:00 Intro
0:30 THC VS CBD
1:02 Biology/neuroscience of CBD
2:50 Research intro
3:26 CBD & anxiety
4:30 CBD & PTSD
5:38 CBD & depression
6:15 CBD & insomnia
8:22 CBD & bipolar disorder
9:30 CBD & ADHD
10:53 CBD & schizophrenia
12:58 General summary
13:37 Future considerations
15:21 Ending summary
https://en.wikipedia.org/wiki Randomized_controlled_trial#:~:text=A%20randomized%20controlled%20trial%20(or,groups%2C%20treating%20them%20differently%2C%20and
https://www.swlondoner.co.uk/life/23042020-cbd-oil-and-relaxation-the-impact-of-cbd-on-the-serotonin-system/
https://www.cbgenius.net/2019/07/09/the-science-of-cbd-is-cannabidiol-a-trpv1-activator/
Sarris et al. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review BMC Psychiatry (2020) 20:24 https://doi.org/10.1186/s12888-019-2409-8
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219–26.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, MartinSantos R, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol (Oxford, UK). 2011;25(1):121–30
Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the treatment of post-traumatic stress disorder: a case series. J Altern Complement Med. 2019;25(4):392–7
Greer GR, Grob CS, Halberstadt AL. PTSD symptom reports of patients evaluated for the New Mexico Medical cannabis Program. J Psychoactive Drugs. 2014;46(1):73–7.
Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, et al. Nabiximols for opioid-treated cancer patients with poorly controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438–49.
Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. Perm J. 2016;20(4):108–11.
Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18–041.
Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/ CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manag. 2013;46(2):207–18
ACTRN12618000078257. A study to evaluate the efficacy of sublingual cannabinoid based medicine extract compared with placebo for the treatment of Insomnia.
Zuardi A, Crippa J, Dursun S, Morais S, Vilela J, Sanches R, et al. Cannabidiol was ineffective for manic episode of bipolar affective disorder. J Psychopharmacol. 2010;24:135 –7.
Mitchell JT, Sweitzer MM, Tunno AM, Kollins SH, McClernon FJ. “I use weed for my ADHD ”: a qualitative analysis of online forum discussions on cannabis use and ADHD. PloS one. 2016;11(5):e0156614.
Marijuana and Medicine: The Need for a Science-Based Approach: Hearing before the Subcommittee on Criminal Justice, Drug Policy and Human
n Resources, U.S. House of Representatives, Second Sess. (April 1, 2004).
Cooper RE, Williams E, Seegobin S, Tye C, Kuntsi J, Asherson P. Cannabinoids in attention-deficit/hyperactivity disorder: a randomised controlled trial. Eur Neuropsychopharmacol. 2017;27(8):795–808.Can cannabis treat mental illness? [FBKJkcs7mlw]
Hi all, the next science video is looking at cannabis/CBD to treat mental illness. This includes CBD for anxiety, depression, bipolar, ADHD, insomnia, schizophrenia, and PTSD. I go into the neuroscience behind cannabis and review recent research and future directions! Please like, subscribe, or comment below on your thoughts for future videos!
0:00 Intro
0:30 THC VS CBD
1:02 Biology/neuroscience of CBD
2:50 Research intro
3:26 CBD & anxiety
4:30 CBD & PTSD
5:38 CBD & depression
6:15 CBD & insomnia
8:22 CBD & bipolar disorder
9:30 CBD & ADHD
10:53 CBD & schizophrenia
12:58 General summary
13:37 Future considerations
15:21 Ending summary
https://en.wikipedia.org/wiki Randomized_controlled_trial#:~:text=A%20randomized%20controlled%20trial%20(or,groups%2C%20treating%20them%20differently%2C%20and
https://www.swlondoner.co.uk/life/23042020-cbd-oil-and-relaxation-the-impact-of-cbd-on-the-serotonin-system/
https://www.cbgenius.net/2019/07/09/the-science-of-cbd-is-cannabidiol-a-trpv1-activator/
Sarris et al. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review BMC Psychiatry (2020) 20:24 https://doi.org/10.1186/s12888-019-2409-8
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219–26.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, MartinSantos R, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol (Oxford, UK). 2011;25(1):121–30
Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the treatment of post-traumatic stress disorder: a case series. J Altern Complement Med. 2019;25(4):392–7
Greer GR, Grob CS, Halberstadt AL. PTSD symptom reports of patients evaluated for the New Mexico Medical cannabis Program. J Psychoactive Drugs. 2014;46(1):73–7.
Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, et al. Nabiximols for opioid-treated cancer patients with poorly controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438–49.
Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. Perm J. 2016;20(4):108–11.
Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18–041.
Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/ CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manag. 2013;46(2):207–18
ACTRN12618000078257. A study to evaluate the efficacy of sublingual cannabinoid based medicine extract compared with placebo for the treatment of Insomnia.
Zuardi A, Crippa J, Dursun S, Morais S, Vilela J, Sanches R, et al. Cannabidiol was ineffective for manic episode of bipolar affective disorder. J Psychopharmacol. 2010;24:135 –7.
Mitchell JT, Sweitzer MM, Tunno AM, Kollins SH, McClernon FJ. “I use weed for my ADHD ”: a qualitative analysis of online forum discussions on cannabis use and ADHD. PloS one. 2016;11(5):e0156614.
Marijuana and Medicine: The Need for a Science-Based Approach: Hearing before the Subcommittee on Criminal Justice, Drug Policy and Human
n Resources, U.S. House of Representatives, Second Sess. (April 1, 2004).
Cooper RE, Williams E, Seegobin S, Tye C, Kuntsi J, Asherson P. Cannabinoids in attention-deficit/hyperactivity disorder: a randomised controlled trial. Eur Neuropsychopharmacol. 2017;27(8):795–808.
